

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 5.96887408 |
| 2 | locomotory exploration behavior (GO:0035641) | 5.78064491 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.68744141 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.29174582 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.15127045 |
| 6 | vocalization behavior (GO:0071625) | 5.09553573 |
| 7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.92061033 |
| 8 | layer formation in cerebral cortex (GO:0021819) | 4.81335623 |
| 9 | synaptic vesicle exocytosis (GO:0016079) | 4.73787170 |
| 10 | regulation of synapse structural plasticity (GO:0051823) | 4.69739279 |
| 11 | glutamate secretion (GO:0014047) | 4.68309936 |
| 12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.65175343 |
| 13 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.58936433 |
| 14 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.57926481 |
| 15 | exploration behavior (GO:0035640) | 4.42154298 |
| 16 | dendritic spine morphogenesis (GO:0060997) | 4.37054880 |
| 17 | protein localization to synapse (GO:0035418) | 4.23618257 |
| 18 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.23085131 |
| 19 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.18250068 |
| 20 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.06833405 |
| 21 | proline transport (GO:0015824) | 4.06408862 |
| 22 | neurotransmitter secretion (GO:0007269) | 4.04721319 |
| 23 | regulation of synaptic vesicle transport (GO:1902803) | 4.03937062 |
| 24 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.03312628 |
| 25 | neuron cell-cell adhesion (GO:0007158) | 3.84203472 |
| 26 | activation of protein kinase A activity (GO:0034199) | 3.73478800 |
| 27 | gamma-aminobutyric acid transport (GO:0015812) | 3.68011784 |
| 28 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.65764563 |
| 29 | sodium ion export (GO:0071436) | 3.65559176 |
| 30 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.61879810 |
| 31 | synaptic transmission, glutamatergic (GO:0035249) | 3.60914466 |
| 32 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.56330397 |
| 33 | cellular potassium ion homeostasis (GO:0030007) | 3.56053744 |
| 34 | dendrite morphogenesis (GO:0048813) | 3.55571660 |
| 35 | long-term memory (GO:0007616) | 3.53333129 |
| 36 | glutamate receptor signaling pathway (GO:0007215) | 3.51044104 |
| 37 | neuronal action potential propagation (GO:0019227) | 3.48755160 |
| 38 | positive regulation of membrane potential (GO:0045838) | 3.48136437 |
| 39 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.45591869 |
| 40 | neuromuscular process controlling balance (GO:0050885) | 3.39379853 |
| 41 | neuron recognition (GO:0008038) | 3.35907971 |
| 42 | neuron-neuron synaptic transmission (GO:0007270) | 3.33132664 |
| 43 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.28897218 |
| 44 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.24951639 |
| 45 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.24887499 |
| 46 | regulation of postsynaptic membrane potential (GO:0060078) | 3.24682635 |
| 47 | cell communication by electrical coupling (GO:0010644) | 3.22886361 |
| 48 | auditory behavior (GO:0031223) | 3.22741388 |
| 49 | positive regulation of synapse maturation (GO:0090129) | 3.21966860 |
| 50 | regulation of synaptic plasticity (GO:0048167) | 3.20896445 |
| 51 | prepulse inhibition (GO:0060134) | 3.16526639 |
| 52 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.15705067 |
| 53 | axonal fasciculation (GO:0007413) | 3.15129386 |
| 54 | glycine transport (GO:0015816) | 3.15119514 |
| 55 | neurotransmitter transport (GO:0006836) | 3.15089526 |
| 56 | regulation of ARF protein signal transduction (GO:0032012) | 3.14420432 |
| 57 | dendritic spine organization (GO:0097061) | 3.11838219 |
| 58 | transmission of nerve impulse (GO:0019226) | 3.09732823 |
| 59 | response to auditory stimulus (GO:0010996) | 3.08248447 |
| 60 | regulation of dendritic spine development (GO:0060998) | 3.02827080 |
| 61 | regulation of neurotransmitter secretion (GO:0046928) | 3.01944779 |
| 62 | vesicle transport along microtubule (GO:0047496) | 3.00292845 |
| 63 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.99449004 |
| 64 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.96867131 |
| 65 | postsynaptic membrane organization (GO:0001941) | 2.96628544 |
| 66 | regulation of neurotransmitter levels (GO:0001505) | 2.96270619 |
| 67 | positive regulation of dendritic spine development (GO:0060999) | 2.96246821 |
| 68 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.95933028 |
| 69 | synaptic vesicle endocytosis (GO:0048488) | 2.95790928 |
| 70 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.95503097 |
| 71 | neuronal ion channel clustering (GO:0045161) | 2.93890286 |
| 72 | long-term synaptic potentiation (GO:0060291) | 2.90878340 |
| 73 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.90406501 |
| 74 | regulation of female receptivity (GO:0045924) | 2.89830410 |
| 75 | cell migration in hindbrain (GO:0021535) | 2.89693410 |
| 76 | clathrin coat assembly (GO:0048268) | 2.87156135 |
| 77 | dopamine receptor signaling pathway (GO:0007212) | 2.85389966 |
| 78 | regulation of vesicle fusion (GO:0031338) | 2.83291450 |
| 79 | positive regulation of neurotransmitter transport (GO:0051590) | 2.82622721 |
| 80 | membrane depolarization (GO:0051899) | 2.81819131 |
| 81 | membrane depolarization during action potential (GO:0086010) | 2.80731545 |
| 82 | organelle transport along microtubule (GO:0072384) | 2.80096646 |
| 83 | innervation (GO:0060384) | 2.78718226 |
| 84 | regulation of neurotransmitter transport (GO:0051588) | 2.77600139 |
| 85 | synapse assembly (GO:0007416) | 2.77529177 |
| 86 | establishment of nucleus localization (GO:0040023) | 2.76371054 |
| 87 | axonemal dynein complex assembly (GO:0070286) | 2.76253857 |
| 88 | alanine transport (GO:0032328) | 2.75198567 |
| 89 | mating behavior (GO:0007617) | 2.72724991 |
| 90 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.72513399 |
| 91 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.72151225 |
| 92 | learning (GO:0007612) | 2.71661423 |
| 93 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.70835072 |
| 94 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.70776208 |
| 95 | membrane hyperpolarization (GO:0060081) | 2.70444470 |
| 96 | intraspecies interaction between organisms (GO:0051703) | 2.70003808 |
| 97 | social behavior (GO:0035176) | 2.70003808 |
| 98 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.69260450 |
| 99 | cell communication involved in cardiac conduction (GO:0086065) | 2.69015928 |
| 100 | synapse organization (GO:0050808) | 2.68914076 |
| 101 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.66902616 |
| 102 | potassium ion import (GO:0010107) | 2.66823505 |
| 103 | motile cilium assembly (GO:0044458) | 2.64547037 |
| 104 | axoneme assembly (GO:0035082) | 2.57772698 |
| 105 | behavioral response to nicotine (GO:0035095) | 2.56592896 |
| 106 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 2.54598721 |
| 107 | positive regulation of protein kinase C signaling (GO:0090037) | 2.50900584 |
| 108 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.44516824 |
| 109 | regulation of skeletal muscle contraction (GO:0014819) | 2.44495566 |
| 110 | macroautophagy (GO:0016236) | 2.41879305 |
| 111 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.39225645 |
| 112 | neurotransmitter catabolic process (GO:0042135) | 2.35087683 |
| 113 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.29473342 |
| 114 | response to misfolded protein (GO:0051788) | 2.26980028 |
| 115 | cilium movement (GO:0003341) | 2.26465988 |
| 116 | response to gravity (GO:0009629) | 2.25662610 |
| 117 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.20742083 |
| 118 | neurotransmitter metabolic process (GO:0042133) | 2.20186414 |
| 119 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.18279115 |
| 120 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.11821102 |
| 121 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.11350437 |
| 122 | regulation of synapse maturation (GO:0090128) | 2.10988268 |
| 123 | autophagic vacuole fusion (GO:0000046) | 2.08283941 |
| 124 | opioid receptor signaling pathway (GO:0038003) | 2.07368681 |
| 125 | neurotransmitter biosynthetic process (GO:0042136) | 2.05103481 |
| 126 | urinary tract smooth muscle contraction (GO:0014848) | 2.02146010 |
| 127 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.01974590 |
| 128 | axon ensheathment in central nervous system (GO:0032291) | 2.01892357 |
| 129 | central nervous system myelination (GO:0022010) | 2.01892357 |
| 130 | regulation of respiratory system process (GO:0044065) | 1.97415429 |
| 131 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 1.96076676 |
| 132 | regulation of triglyceride biosynthetic process (GO:0010866) | 1.94786886 |
| 133 | creatine metabolic process (GO:0006600) | 1.92748623 |
| 134 | epithelial cilium movement (GO:0003351) | 1.92283695 |
| 135 | positive regulation of sodium ion transport (GO:0010765) | 1.92274074 |
| 136 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 1.90986178 |
| 137 | neuromuscular synaptic transmission (GO:0007274) | 1.88786034 |
| 138 | positive regulation of lipoprotein lipase activity (GO:0051006) | 1.87191865 |
| 139 | positive regulation of triglyceride lipase activity (GO:0061365) | 1.87191865 |
| 140 | positive regulation of fatty acid oxidation (GO:0046321) | 1.86889743 |
| 141 | dermatan sulfate metabolic process (GO:0030205) | 1.86654543 |
| 142 | regulation of membrane repolarization (GO:0060306) | 1.86440599 |
| 143 | neuronal action potential (GO:0019228) | 1.85014489 |
| 144 | cellular response to ATP (GO:0071318) | 1.84002643 |
| 145 | protein localization to cilium (GO:0061512) | 1.83707263 |
| 146 | left/right pattern formation (GO:0060972) | 1.83640880 |
| 147 | cerebellar granule cell differentiation (GO:0021707) | 1.82323542 |
| 148 | serotonin metabolic process (GO:0042428) | 1.81852044 |
| 149 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 1.81592480 |
| 150 | regulation of microtubule-based movement (GO:0060632) | 1.81301574 |
| 151 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 1.81223079 |
| 152 | negative regulation of protein localization to cell surface (GO:2000009) | 1.80984562 |
| 153 | one-carbon compound transport (GO:0019755) | 1.80696810 |
| 154 | adaptation of signaling pathway (GO:0023058) | 1.80372353 |
| 155 | positive regulation of triglyceride metabolic process (GO:0090208) | 1.79232228 |
| 156 | positive regulation of dendrite development (GO:1900006) | 1.79117412 |
| 157 | startle response (GO:0001964) | 1.78259028 |
| 158 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 1.76344296 |
| 159 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 1.76344296 |
| 160 | primary amino compound metabolic process (GO:1901160) | 1.76050596 |
| 161 | glycerophospholipid catabolic process (GO:0046475) | 1.75181487 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.17135134 |
| 2 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.88512586 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.85073257 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.83253848 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.81453285 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.79846483 |
| 7 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.68650838 |
| 8 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.62731085 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.58078249 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.58078249 |
| 11 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.49523460 |
| 12 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.47111562 |
| 13 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.45852659 |
| 14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.45610872 |
| 15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.39495409 |
| 16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.37499978 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.33902996 |
| 18 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.29878670 |
| 19 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.28678147 |
| 20 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.25624985 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.21172114 |
| 22 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.20199576 |
| 23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.19797201 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.10118726 |
| 25 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.04591310 |
| 26 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.03142496 |
| 27 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.02042455 |
| 28 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.92209532 |
| 29 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.84030509 |
| 30 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.83377481 |
| 31 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.75139901 |
| 32 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.69479176 |
| 33 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.65696433 |
| 34 | * NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.65472450 |
| 35 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.64975862 |
| 36 | * P68_20966046_ChIP-Seq_HELA_Human | 1.62345448 |
| 37 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.62245639 |
| 38 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.56977385 |
| 39 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.55991103 |
| 40 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.51095717 |
| 41 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.45795209 |
| 42 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.39183541 |
| 43 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.38961809 |
| 44 | KDM2B_26808549_Chip-Seq_K562_Human | 1.38585734 |
| 45 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.37838175 |
| 46 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.37362264 |
| 47 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.36954544 |
| 48 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.36555633 |
| 49 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.36428046 |
| 50 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.35307807 |
| 51 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.33563221 |
| 52 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.33144926 |
| 53 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.32819819 |
| 54 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.32293421 |
| 55 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.32197042 |
| 56 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.31926779 |
| 57 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.29870884 |
| 58 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28974776 |
| 59 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.28816051 |
| 60 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.28167211 |
| 61 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.27638328 |
| 62 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.27618905 |
| 63 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.26883752 |
| 64 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.23354106 |
| 65 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.22312679 |
| 66 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.21395305 |
| 67 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.20233837 |
| 68 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.19426536 |
| 69 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.19382674 |
| 70 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.19232802 |
| 71 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.18174835 |
| 72 | AR_19668381_ChIP-Seq_PC3_Human | 1.17204087 |
| 73 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.16945487 |
| 74 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.16672870 |
| 75 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.16226497 |
| 76 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.15978236 |
| 77 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.13244971 |
| 78 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13206947 |
| 79 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.11581794 |
| 80 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.11452670 |
| 81 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.11197227 |
| 82 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.11122095 |
| 83 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.11044935 |
| 84 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.10251596 |
| 85 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.10151409 |
| 86 | SA1_27219007_Chip-Seq_Bcells_Human | 1.09943464 |
| 87 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.09359293 |
| 88 | AR_25329375_ChIP-Seq_VCAP_Human | 1.08366849 |
| 89 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.07323473 |
| 90 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.07202660 |
| 91 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.07163115 |
| 92 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.06433290 |
| 93 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.06001994 |
| 94 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05073013 |
| 95 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.04384295 |
| 96 | STAT3_23295773_ChIP-Seq_U87_Human | 1.02881154 |
| 97 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.01762342 |
| 98 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.01405292 |
| 99 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01250266 |
| 100 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.00707563 |
| 101 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.00623785 |
| 102 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.00544772 |
| 103 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.00284102 |
| 104 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.99542961 |
| 105 | ERA_21632823_ChIP-Seq_H3396_Human | 0.98182070 |
| 106 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.97334904 |
| 107 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97318193 |
| 108 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.96967723 |
| 109 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96634855 |
| 110 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.96014337 |
| 111 | P300_19829295_ChIP-Seq_ESCs_Human | 0.95717305 |
| 112 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.95676410 |
| 113 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.95410790 |
| 114 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.94944536 |
| 115 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.94504346 |
| 116 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.94315035 |
| 117 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94074559 |
| 118 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.93346903 |
| 119 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.93330495 |
| 120 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.93305363 |
| 121 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.92896543 |
| 122 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.92794670 |
| 123 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.92559042 |
| 124 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.92515410 |
| 125 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.92368177 |
| 126 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.92199115 |
| 127 | TP53_16413492_ChIP-PET_HCT116_Human | 0.91950979 |
| 128 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.91926353 |
| 129 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.91807246 |
| 130 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.91788251 |
| 131 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.91706953 |
| 132 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.91570741 |
| 133 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.91373158 |
| 134 | GATA1_19941826_ChIP-Seq_K562_Human | 0.91319129 |
| 135 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.91288188 |
| 136 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.91257870 |
| 137 | TCF4_23295773_ChIP-Seq_U87_Human | 0.90909413 |
| 138 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.90557068 |
| 139 | P300_27268052_Chip-Seq_Bcells_Human | 0.89910598 |
| 140 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.89373976 |
| 141 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88829079 |
| 142 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.88781834 |
| 143 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.88718281 |
| 144 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.87998050 |
| 145 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.87497355 |
| 146 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.87350508 |
| 147 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.86908529 |
| 148 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.86622603 |
| 149 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.86278169 |
| 150 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.85987027 |
| 151 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.85874152 |
| 152 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.85829744 |
| 153 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.85206757 |
| 154 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.85057417 |
| 155 | RXR_22108803_ChIP-Seq_LS180_Human | 0.84807873 |
| 156 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.84605918 |
| 157 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.83056564 |
| 158 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82734228 |
| 159 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.82667494 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.92390702 |
| 2 | MP0003635_abnormal_synaptic_transmissio | 4.15346930 |
| 3 | MP0004270_analgesia | 3.92152528 |
| 4 | MP0003880_abnormal_central_pattern | 3.88854493 |
| 5 | MP0002063_abnormal_learning/memory/cond | 3.36573604 |
| 6 | MP0009745_abnormal_behavioral_response | 3.24251742 |
| 7 | MP0002822_catalepsy | 2.92467291 |
| 8 | MP0002064_seizures | 2.91518637 |
| 9 | MP0005423_abnormal_somatic_nervous | 2.90478953 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.65596139 |
| 11 | MP0002653_abnormal_ependyma_morphology | 2.64710462 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.63185792 |
| 13 | MP0009046_muscle_twitch | 2.62990020 |
| 14 | MP0009780_abnormal_chondrocyte_physiolo | 2.62682026 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.56244557 |
| 16 | MP0001486_abnormal_startle_reflex | 2.47049004 |
| 17 | MP0002909_abnormal_adrenal_gland | 2.42121007 |
| 18 | MP0002272_abnormal_nervous_system | 2.27561441 |
| 19 | MP0003329_amyloid_beta_deposits | 2.15902947 |
| 20 | MP0002733_abnormal_thermal_nociception | 1.98534104 |
| 21 | MP0004858_abnormal_nervous_system | 1.96866145 |
| 22 | MP0001440_abnormal_grooming_behavior | 1.96237646 |
| 23 | MP0008569_lethality_at_weaning | 1.93245042 |
| 24 | MP0002735_abnormal_chemical_nociception | 1.92945585 |
| 25 | MP0001501_abnormal_sleep_pattern | 1.91952888 |
| 26 | MP0002736_abnormal_nociception_after | 1.90954364 |
| 27 | MP0000778_abnormal_nervous_system | 1.90950936 |
| 28 | MP0004811_abnormal_neuron_physiology | 1.86322006 |
| 29 | MP0001970_abnormal_pain_threshold | 1.84870363 |
| 30 | MP0004885_abnormal_endolymph | 1.73685250 |
| 31 | MP0002557_abnormal_social/conspecific_i | 1.72240768 |
| 32 | MP0004924_abnormal_behavior | 1.71304671 |
| 33 | MP0005386_behavior/neurological_phenoty | 1.71304671 |
| 34 | MP0002067_abnormal_sensory_capabilities | 1.71264926 |
| 35 | MP0003879_abnormal_hair_cell | 1.67806858 |
| 36 | MP0002184_abnormal_innervation | 1.67366057 |
| 37 | MP0000569_abnormal_digit_pigmentation | 1.66730969 |
| 38 | MP0000955_abnormal_spinal_cord | 1.57255084 |
| 39 | MP0002876_abnormal_thyroid_physiology | 1.54879960 |
| 40 | MP0008875_abnormal_xenobiotic_pharmacok | 1.53610939 |
| 41 | MP0005670_abnormal_white_adipose | 1.52260281 |
| 42 | MP0003633_abnormal_nervous_system | 1.44271933 |
| 43 | MP0005646_abnormal_pituitary_gland | 1.43716254 |
| 44 | MP0000751_myopathy | 1.42129431 |
| 45 | MP0005058_abnormal_lysosome_morphology | 1.40702616 |
| 46 | MP0003646_muscle_fatigue | 1.39795096 |
| 47 | MP0002882_abnormal_neuron_morphology | 1.36906341 |
| 48 | MP0002066_abnormal_motor_capabilities/c | 1.36435330 |
| 49 | MP0009840_abnormal_foam_cell | 1.33985325 |
| 50 | MP0001986_abnormal_taste_sensitivity | 1.27914589 |
| 51 | MP0008961_abnormal_basal_metabolism | 1.27300202 |
| 52 | MP0001984_abnormal_olfaction | 1.26331901 |
| 53 | MP0002332_abnormal_exercise_endurance | 1.21334293 |
| 54 | MP0003045_fibrosis | 1.19764568 |
| 55 | MP0010234_abnormal_vibrissa_follicle | 1.19651766 |
| 56 | MP0003787_abnormal_imprinting | 1.19249714 |
| 57 | MP0005645_abnormal_hypothalamus_physiol | 1.18080023 |
| 58 | MP0001502_abnormal_circadian_rhythm | 1.16981040 |
| 59 | MP0004130_abnormal_muscle_cell | 1.16580546 |
| 60 | MP0006276_abnormal_autonomic_nervous | 1.16332827 |
| 61 | MP0010329_abnormal_lipoprotein_level | 1.15287804 |
| 62 | MP0003631_nervous_system_phenotype | 1.14775042 |
| 63 | MP0005083_abnormal_biliary_tract | 1.13845373 |
| 64 | MP0003690_abnormal_glial_cell | 1.12737672 |
| 65 | MP0002837_dystrophic_cardiac_calcinosis | 1.12174747 |
| 66 | MP0000681_abnormal_thyroid_gland | 1.10490559 |
| 67 | MP0001958_emphysema | 1.09685397 |
| 68 | MP0003075_altered_response_to | 1.09379420 |
| 69 | MP0000604_amyloidosis | 1.09151092 |
| 70 | MP0002152_abnormal_brain_morphology | 1.09117497 |
| 71 | MP0005365_abnormal_bile_salt | 1.08134242 |
| 72 | MP0000749_muscle_degeneration | 1.06995755 |
| 73 | MP0000013_abnormal_adipose_tissue | 1.06853505 |
| 74 | MP0002249_abnormal_larynx_morphology | 1.06782581 |
| 75 | MP0003183_abnormal_peptide_metabolism | 1.05420223 |
| 76 | MP0000230_abnormal_systemic_arterial | 1.05247577 |
| 77 | MP0004085_abnormal_heartbeat | 1.04507511 |
| 78 | MP0005595_abnormal_vascular_smooth | 1.00240377 |
| 79 | MP0005448_abnormal_energy_balance | 0.99743669 |
| 80 | MP0005535_abnormal_body_temperature | 0.99163122 |
| 81 | MP0003634_abnormal_glial_cell | 0.98773096 |
| 82 | MP0003283_abnormal_digestive_organ | 0.97942572 |
| 83 | MP0002069_abnormal_eating/drinking_beha | 0.97353627 |
| 84 | MP0003279_aneurysm | 0.96997662 |
| 85 | MP0002638_abnormal_pupillary_reflex | 0.96479580 |
| 86 | MP0008874_decreased_physiological_sensi | 0.96342851 |
| 87 | MP0000750_abnormal_muscle_regeneration | 0.95390821 |
| 88 | MP0003172_abnormal_lysosome_physiology | 0.95229603 |
| 89 | MP0003011_delayed_dark_adaptation | 0.94827161 |
| 90 | MP0001905_abnormal_dopamine_level | 0.94316196 |
| 91 | MP0000920_abnormal_myelination | 0.93807444 |
| 92 | MP0001177_atelectasis | 0.92306680 |
| 93 | MP0002090_abnormal_vision | 0.90319038 |
| 94 | MP0004215_abnormal_myocardial_fiber | 0.89875084 |
| 95 | MP0004510_myositis | 0.89844846 |
| 96 | MP0002229_neurodegeneration | 0.89254491 |
| 97 | MP0002118_abnormal_lipid_homeostasis | 0.86972411 |
| 98 | MP0000026_abnormal_inner_ear | 0.86328635 |
| 99 | MP0004133_heterotaxia | 0.85131113 |
| 100 | MP0002933_joint_inflammation | 0.84578368 |
| 101 | MP0003137_abnormal_impulse_conducting | 0.84231682 |
| 102 | MP0003136_yellow_coat_color | 0.83356901 |
| 103 | MP0001765_abnormal_ion_homeostasis | 0.82222260 |
| 104 | MP0004147_increased_porphyrin_level | 0.81200918 |
| 105 | MP0009764_decreased_sensitivity_to | 0.81133359 |
| 106 | MP0000678_abnormal_parathyroid_gland | 0.81121486 |
| 107 | MP0001529_abnormal_vocalization | 0.79296358 |
| 108 | MP0004142_abnormal_muscle_tone | 0.77673825 |
| 109 | MP0005167_abnormal_blood-brain_barrier | 0.77411679 |
| 110 | MP0003632_abnormal_nervous_system | 0.76612888 |
| 111 | MP0005187_abnormal_penis_morphology | 0.76108825 |
| 112 | MP0008872_abnormal_physiological_respon | 0.75662789 |
| 113 | MP0004145_abnormal_muscle_electrophysio | 0.75333582 |
| 114 | MP0010386_abnormal_urinary_bladder | 0.74975633 |
| 115 | MP0003122_maternal_imprinting | 0.73395046 |
| 116 | MP0008775_abnormal_heart_ventricle | 0.72328255 |
| 117 | MP0004036_abnormal_muscle_relaxation | 0.72177429 |
| 118 | MP0004484_altered_response_of | 0.69991845 |
| 119 | MP0000631_abnormal_neuroendocrine_gland | 0.65804659 |
| 120 | MP0004742_abnormal_vestibular_system | 0.64612433 |
| 121 | MP0001963_abnormal_hearing_physiology | 0.64553420 |
| 122 | MP0004043_abnormal_pH_regulation | 0.63683513 |
| 123 | MP0001664_abnormal_digestion | 0.62159232 |
| 124 | MP0001348_abnormal_lacrimal_gland | 0.60471634 |
| 125 | MP0005551_abnormal_eye_electrophysiolog | 0.59524730 |
| 126 | MP0002234_abnormal_pharynx_morphology | 0.59072416 |
| 127 | MP0002752_abnormal_somatic_nervous | 0.58662372 |
| 128 | MP0001188_hyperpigmentation | 0.58109103 |
| 129 | MP0005620_abnormal_muscle_contractility | 0.57985606 |
| 130 | MP0005623_abnormal_meninges_morphology | 0.56427369 |
| 131 | MP0001299_abnormal_eye_distance/ | 0.56426991 |
| 132 | MP0000747_muscle_weakness | 0.53333575 |
| 133 | MP0004233_abnormal_muscle_weight | 0.52674477 |
| 134 | MP0001943_abnormal_respiration | 0.52536274 |
| 135 | MP0003303_peritoneal_inflammation | 0.51741701 |
| 136 | MP0003861_abnormal_nervous_system | 0.51398891 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 6.57206151 |
| 2 | Focal motor seizures (HP:0011153) | 5.91110207 |
| 3 | Visual hallucinations (HP:0002367) | 4.95017137 |
| 4 | Focal seizures (HP:0007359) | 4.94488769 |
| 5 | Supranuclear gaze palsy (HP:0000605) | 4.21104601 |
| 6 | Epileptic encephalopathy (HP:0200134) | 3.90427223 |
| 7 | Ankle clonus (HP:0011448) | 3.87758188 |
| 8 | Action tremor (HP:0002345) | 3.86516533 |
| 9 | Papilledema (HP:0001085) | 3.84740544 |
| 10 | Mutism (HP:0002300) | 3.55144474 |
| 11 | Progressive cerebellar ataxia (HP:0002073) | 3.49372221 |
| 12 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.42219450 |
| 13 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.42219450 |
| 14 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.38211318 |
| 15 | Absent/shortened dynein arms (HP:0200106) | 3.38211318 |
| 16 | J-shaped sella turcica (HP:0002680) | 3.37471202 |
| 17 | Atonic seizures (HP:0010819) | 3.35522635 |
| 18 | Poor eye contact (HP:0000817) | 3.31128183 |
| 19 | Absence seizures (HP:0002121) | 3.28031110 |
| 20 | Broad-based gait (HP:0002136) | 3.26162205 |
| 21 | Depression (HP:0000716) | 3.24564062 |
| 22 | Generalized tonic-clonic seizures (HP:0002069) | 3.20412078 |
| 23 | Neurofibrillary tangles (HP:0002185) | 3.16742369 |
| 24 | Febrile seizures (HP:0002373) | 3.13304991 |
| 25 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.11854463 |
| 26 | Abnormal social behavior (HP:0012433) | 3.11155145 |
| 27 | Impaired social interactions (HP:0000735) | 3.11155145 |
| 28 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.10461208 |
| 29 | Abnormal ciliary motility (HP:0012262) | 3.08800833 |
| 30 | Torticollis (HP:0000473) | 3.08651527 |
| 31 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.07284667 |
| 32 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.05294538 |
| 33 | Postural instability (HP:0002172) | 3.00524328 |
| 34 | Cerebral inclusion bodies (HP:0100314) | 3.00092153 |
| 35 | Anxiety (HP:0000739) | 2.97922696 |
| 36 | Dialeptic seizures (HP:0011146) | 2.97548697 |
| 37 | Urinary urgency (HP:0000012) | 2.91215541 |
| 38 | Decreased circulating renin level (HP:0003351) | 2.88257081 |
| 39 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.86042678 |
| 40 | Dysmetria (HP:0001310) | 2.84742755 |
| 41 | Intention tremor (HP:0002080) | 2.83446974 |
| 42 | Dysostosis multiplex (HP:0000943) | 2.82330109 |
| 43 | Dysdiadochokinesis (HP:0002075) | 2.81571869 |
| 44 | Megalencephaly (HP:0001355) | 2.77063857 |
| 45 | Focal dystonia (HP:0004373) | 2.76006367 |
| 46 | Abnormal eating behavior (HP:0100738) | 2.72239013 |
| 47 | Abnormality of the lower motor neuron (HP:0002366) | 2.71975309 |
| 48 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.68716060 |
| 49 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.68716060 |
| 50 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.68716060 |
| 51 | Drooling (HP:0002307) | 2.67834153 |
| 52 | Excessive salivation (HP:0003781) | 2.67834153 |
| 53 | Amblyopia (HP:0000646) | 2.63015511 |
| 54 | Ventricular fibrillation (HP:0001663) | 2.62996413 |
| 55 | Hyperventilation (HP:0002883) | 2.62189442 |
| 56 | Spastic gait (HP:0002064) | 2.60051605 |
| 57 | Genetic anticipation (HP:0003743) | 2.59231725 |
| 58 | Gaze-evoked nystagmus (HP:0000640) | 2.57998310 |
| 59 | Craniofacial dystonia (HP:0012179) | 2.55932459 |
| 60 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.55291653 |
| 61 | Truncal ataxia (HP:0002078) | 2.55257915 |
| 62 | Progressive inability to walk (HP:0002505) | 2.54656301 |
| 63 | Abnormality of the nasal mucosa (HP:0000433) | 2.53012755 |
| 64 | Cystic liver disease (HP:0006706) | 2.49760574 |
| 65 | Stereotypic behavior (HP:0000733) | 2.48597592 |
| 66 | Rhinitis (HP:0012384) | 2.48128987 |
| 67 | Bundle branch block (HP:0011710) | 2.46518915 |
| 68 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.46043225 |
| 69 | Mucopolysacchariduria (HP:0008155) | 2.46043225 |
| 70 | Hemiparesis (HP:0001269) | 2.43638952 |
| 71 | Molar tooth sign on MRI (HP:0002419) | 2.42455599 |
| 72 | Abnormality of midbrain morphology (HP:0002418) | 2.42455599 |
| 73 | Insomnia (HP:0100785) | 2.42086753 |
| 74 | Limb dystonia (HP:0002451) | 2.41817311 |
| 75 | Diplopia (HP:0000651) | 2.41497639 |
| 76 | Abnormality of binocular vision (HP:0011514) | 2.41497639 |
| 77 | Abnormality of the corticospinal tract (HP:0002492) | 2.41227591 |
| 78 | Amyotrophic lateral sclerosis (HP:0007354) | 2.39665559 |
| 79 | Abnormality of glycolipid metabolism (HP:0010969) | 2.36320161 |
| 80 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.36320161 |
| 81 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.36320161 |
| 82 | Bradykinesia (HP:0002067) | 2.36298662 |
| 83 | Increased cerebral lipofuscin (HP:0011813) | 2.35653506 |
| 84 | Nasal polyposis (HP:0100582) | 2.34820866 |
| 85 | Termporal pattern (HP:0011008) | 2.34532815 |
| 86 | Insidious onset (HP:0003587) | 2.34532815 |
| 87 | Lower limb muscle weakness (HP:0007340) | 2.34512287 |
| 88 | Inappropriate behavior (HP:0000719) | 2.33454288 |
| 89 | Pancreatic cysts (HP:0001737) | 2.33412531 |
| 90 | Hemiplegia (HP:0002301) | 2.31798627 |
| 91 | True hermaphroditism (HP:0010459) | 2.30075563 |
| 92 | Akinesia (HP:0002304) | 2.30022193 |
| 93 | Agitation (HP:0000713) | 2.27839634 |
| 94 | Impaired smooth pursuit (HP:0007772) | 2.27315753 |
| 95 | EEG with generalized epileptiform discharges (HP:0011198) | 2.26813841 |
| 96 | Apathy (HP:0000741) | 2.26500292 |
| 97 | Epileptiform EEG discharges (HP:0011182) | 2.25775635 |
| 98 | Hypsarrhythmia (HP:0002521) | 2.24259451 |
| 99 | Obstructive sleep apnea (HP:0002870) | 2.22028305 |
| 100 | Scanning speech (HP:0002168) | 2.21968532 |
| 101 | Mesangial abnormality (HP:0001966) | 2.20845548 |
| 102 | Stridor (HP:0010307) | 2.20375458 |
| 103 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.17076746 |
| 104 | Pointed chin (HP:0000307) | 2.16531097 |
| 105 | Muscle fiber splitting (HP:0003555) | 2.16369557 |
| 106 | Clonus (HP:0002169) | 2.13501010 |
| 107 | Fetal akinesia sequence (HP:0001989) | 2.13292739 |
| 108 | Nephronophthisis (HP:0000090) | 2.12141094 |
| 109 | Neuronal loss in central nervous system (HP:0002529) | 2.11127824 |
| 110 | Pheochromocytoma (HP:0002666) | 2.11065821 |
| 111 | Dysmetric saccades (HP:0000641) | 2.11056617 |
| 112 | Cerebral palsy (HP:0100021) | 2.10457605 |
| 113 | Abnormal EKG (HP:0003115) | 2.08388269 |
| 114 | Prolonged QT interval (HP:0001657) | 2.07907113 |
| 115 | Clumsiness (HP:0002312) | 2.06826212 |
| 116 | Lower limb amyotrophy (HP:0007210) | 2.06182793 |
| 117 | Polydipsia (HP:0001959) | 2.05256718 |
| 118 | Abnormal drinking behavior (HP:0030082) | 2.05256718 |
| 119 | Pancreatic fibrosis (HP:0100732) | 2.04705988 |
| 120 | Impaired vibratory sensation (HP:0002495) | 2.04422142 |
| 121 | Severe muscular hypotonia (HP:0006829) | 2.03945242 |
| 122 | Ankyloglossia (HP:0010296) | 2.03280502 |
| 123 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.02709239 |
| 124 | Rapidly progressive (HP:0003678) | 2.01850798 |
| 125 | Status epilepticus (HP:0002133) | 2.00120186 |
| 126 | Polyphagia (HP:0002591) | 1.99984378 |
| 127 | Macroorchidism (HP:0000053) | 1.99267252 |
| 128 | Asymmetric septal hypertrophy (HP:0001670) | 1.98236297 |
| 129 | Joint stiffness (HP:0001387) | 1.98010915 |
| 130 | Resting tremor (HP:0002322) | 1.97422620 |
| 131 | Abnormality of renin-angiotensin system (HP:0000847) | 1.97139628 |
| 132 | Diminished motivation (HP:0000745) | 1.95796429 |
| 133 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.95133346 |
| 134 | Distal upper limb amyotrophy (HP:0007149) | 1.94575786 |
| 135 | Upper limb amyotrophy (HP:0009129) | 1.94575786 |
| 136 | Supraventricular tachycardia (HP:0004755) | 1.93469380 |
| 137 | Primary atrial arrhythmia (HP:0001692) | 1.91832306 |
| 138 | Abnormal atrioventricular conduction (HP:0005150) | 1.91122487 |
| 139 | Atrial fibrillation (HP:0005110) | 1.90872121 |
| 140 | Lower limb asymmetry (HP:0100559) | 1.90318491 |
| 141 | Annular pancreas (HP:0001734) | 1.89884293 |
| 142 | Congenital stationary night blindness (HP:0007642) | 1.89130234 |
| 143 | Atelectasis (HP:0100750) | 1.87649053 |
| 144 | Congenital sensorineural hearing impairment (HP:0008527) | 1.87603081 |
| 145 | Supraventricular arrhythmia (HP:0005115) | 1.85957904 |
| 146 | Occipital encephalocele (HP:0002085) | 1.85939019 |
| 147 | Type II lissencephaly (HP:0007260) | 1.82577011 |
| 148 | Generalized myoclonic seizures (HP:0002123) | 1.82109764 |
| 149 | Sudden death (HP:0001699) | 1.80796116 |
| 150 | Rigidity (HP:0002063) | 1.80008501 |
| 151 | Heart block (HP:0012722) | 1.79526041 |
| 152 | Hyperacusis (HP:0010780) | 1.79250169 |
| 153 | Short femoral neck (HP:0100864) | 1.79065684 |
| 154 | Large for gestational age (HP:0001520) | 1.77882813 |
| 155 | Psychosis (HP:0000709) | 1.77347694 |
| 156 | Absent speech (HP:0001344) | 1.76773534 |
| 157 | Lymphangioma (HP:0100764) | 1.75960428 |
| 158 | Abnormality of saccadic eye movements (HP:0000570) | 1.75473038 |
| 159 | Syncope (HP:0001279) | 1.75360807 |
| 160 | Alkalosis (HP:0001948) | 1.74671268 |
| 161 | Sleep apnea (HP:0010535) | 1.72444684 |
| 162 | Difficulty walking (HP:0002355) | 1.70837145 |
| 163 | Anomalous pulmonary venous return (HP:0010772) | 1.69643679 |
| 164 | Hand muscle atrophy (HP:0009130) | 1.67705172 |
| 165 | Abnormality of the renal medulla (HP:0100957) | 1.66442159 |
| 166 | Ventricular arrhythmia (HP:0004308) | 1.65790085 |
| 167 | Distal lower limb muscle weakness (HP:0009053) | 1.65663304 |
| 168 | Bronchomalacia (HP:0002780) | 1.65635903 |
| 169 | Bulbar palsy (HP:0001283) | 1.64765650 |
| 170 | Deformed sella turcica (HP:0002681) | 1.63327934 |
| 171 | Hypoplasia of the odontoid process (HP:0003311) | 1.62476847 |
| 172 | Tubular atrophy (HP:0000092) | 1.62165269 |
| 173 | Myopathic facies (HP:0002058) | 1.59091116 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 4.46575883 |
| 2 | EPHA4 | 4.02429133 |
| 3 | MAP3K9 | 3.81604359 |
| 4 | NTRK3 | 3.68332086 |
| 5 | DAPK2 | 2.67011851 |
| 6 | MINK1 | 2.59883424 |
| 7 | MAPK15 | 2.57995791 |
| 8 | MAP3K4 | 2.51118530 |
| 9 | MAP3K11 | 2.36335027 |
| 10 | KSR2 | 2.22457439 |
| 11 | PAK6 | 2.18305688 |
| 12 | NTRK2 | 2.17790408 |
| 13 | CAMKK1 | 2.15713695 |
| 14 | FRK | 2.12517795 |
| 15 | PRKD3 | 2.10417000 |
| 16 | TLK1 | 2.04592315 |
| 17 | MAP2K7 | 1.92876111 |
| 18 | TNK2 | 1.86700019 |
| 19 | NTRK1 | 1.74734158 |
| 20 | ADRBK2 | 1.70793765 |
| 21 | MAPKAPK3 | 1.67889378 |
| 22 | PHKG1 | 1.66911623 |
| 23 | PHKG2 | 1.66911623 |
| 24 | SIK2 | 1.66715743 |
| 25 | CDK5 | 1.58329603 |
| 26 | TNIK | 1.57704152 |
| 27 | MAP2K4 | 1.56819185 |
| 28 | KSR1 | 1.56218877 |
| 29 | RIPK4 | 1.54292452 |
| 30 | MAP2K6 | 1.54062086 |
| 31 | MAP3K2 | 1.50595642 |
| 32 | SIK1 | 1.43082124 |
| 33 | ERN1 | 1.34836216 |
| 34 | MAPK13 | 1.34792031 |
| 35 | PRKD2 | 1.33067770 |
| 36 | BLK | 1.32483866 |
| 37 | DAPK1 | 1.29462320 |
| 38 | INSRR | 1.27593490 |
| 39 | TESK1 | 1.26171330 |
| 40 | LMTK2 | 1.25004329 |
| 41 | TAOK1 | 1.24786455 |
| 42 | TYRO3 | 1.17355296 |
| 43 | ADRBK1 | 1.16770248 |
| 44 | RET | 1.16122778 |
| 45 | MAP3K12 | 1.15080590 |
| 46 | STK38 | 1.10882671 |
| 47 | LIMK1 | 1.10529731 |
| 48 | RIPK1 | 1.09610866 |
| 49 | CAMKK2 | 1.08565320 |
| 50 | UHMK1 | 1.05258902 |
| 51 | PRPF4B | 1.04361050 |
| 52 | GRK5 | 1.04114367 |
| 53 | MUSK | 1.01344187 |
| 54 | EPHA2 | 0.99463411 |
| 55 | PRKCH | 0.98822855 |
| 56 | TRIB3 | 0.98332342 |
| 57 | FES | 0.97668927 |
| 58 | TBK1 | 0.95450869 |
| 59 | PAK3 | 0.95032858 |
| 60 | CAMK1 | 0.94448531 |
| 61 | PRKCG | 0.92720715 |
| 62 | HIPK2 | 0.91838473 |
| 63 | LATS2 | 0.91723119 |
| 64 | ARAF | 0.91709478 |
| 65 | MAP3K13 | 0.90985657 |
| 66 | MARK2 | 0.90119314 |
| 67 | STK11 | 0.89043259 |
| 68 | EPHB2 | 0.88951709 |
| 69 | WNK4 | 0.87626154 |
| 70 | GRK1 | 0.84792498 |
| 71 | SGK223 | 0.82911771 |
| 72 | SGK494 | 0.82911771 |
| 73 | CDK19 | 0.82188628 |
| 74 | BCKDK | 0.81827858 |
| 75 | CAMK1G | 0.81034574 |
| 76 | PLK2 | 0.78623435 |
| 77 | CAMK2A | 0.78538345 |
| 78 | ABL2 | 0.77558173 |
| 79 | CDK15 | 0.76354852 |
| 80 | CDK18 | 0.75964999 |
| 81 | CSNK1G2 | 0.75657930 |
| 82 | ALK | 0.75572025 |
| 83 | PDK1 | 0.75435815 |
| 84 | KDR | 0.73710941 |
| 85 | CDK14 | 0.73496003 |
| 86 | RPS6KA6 | 0.73296243 |
| 87 | MAP2K2 | 0.73068899 |
| 88 | GRK6 | 0.72914869 |
| 89 | PIM2 | 0.72676776 |
| 90 | SGK3 | 0.72314584 |
| 91 | PDPK1 | 0.70199557 |
| 92 | RAF1 | 0.70070663 |
| 93 | SCYL2 | 0.69942888 |
| 94 | DMPK | 0.69497734 |
| 95 | OBSCN | 0.69442211 |
| 96 | ERBB3 | 0.67224582 |
| 97 | PKN2 | 0.66382732 |
| 98 | CDK11A | 0.66216587 |
| 99 | SGK2 | 0.65733949 |
| 100 | GRK7 | 0.65168270 |
| 101 | MAP2K3 | 0.65110562 |
| 102 | BMX | 0.64638869 |
| 103 | SGK1 | 0.64628740 |
| 104 | PINK1 | 0.64437513 |
| 105 | MAP3K1 | 0.63728529 |
| 106 | PNCK | 0.62476080 |
| 107 | RPS6KA2 | 0.61311072 |
| 108 | FYN | 0.61109666 |
| 109 | PRKCZ | 0.60947367 |
| 110 | FGFR2 | 0.60689252 |
| 111 | PRKD1 | 0.59952482 |
| 112 | PTK2B | 0.59774868 |
| 113 | EPHA3 | 0.58676316 |
| 114 | TIE1 | 0.57562364 |
| 115 | DYRK1A | 0.57218285 |
| 116 | CDC42BPA | 0.56655458 |
| 117 | MAP3K7 | 0.55863984 |
| 118 | ICK | 0.55593275 |
| 119 | CAMK2G | 0.54460977 |
| 120 | MYLK | 0.54365062 |
| 121 | CAMK2B | 0.53423198 |
| 122 | IKBKB | 0.53240731 |
| 123 | RPS6KL1 | 0.52506449 |
| 124 | RPS6KC1 | 0.52506449 |
| 125 | ZAP70 | 0.51053501 |
| 126 | PRKAA1 | 0.50571448 |
| 127 | CAMK4 | 0.50201935 |
| 128 | OXSR1 | 0.49753726 |
| 129 | RPS6KA3 | 0.49238650 |
| 130 | CASK | 0.48638135 |
| 131 | IRAK3 | 0.48570994 |
| 132 | MAPK7 | 0.48477034 |
| 133 | PRKAA2 | 0.48027842 |
| 134 | EPHB1 | 0.47860619 |
| 135 | MAP2K1 | 0.46381996 |
| 136 | TAOK3 | 0.46141846 |
| 137 | MAPK12 | 0.45344258 |
| 138 | PRKCE | 0.42676093 |
| 139 | PDGFRA | 0.42140766 |
| 140 | NEK6 | 0.35732085 |
| 141 | PKN1 | 0.35364591 |
| 142 | FGR | 0.34324949 |
| 143 | DYRK2 | 0.34317502 |
| 144 | MAPK10 | 0.33555969 |
| 145 | DAPK3 | 0.33391264 |
| 146 | ROCK1 | 0.33175343 |
| 147 | MAP3K6 | 0.32745272 |
| 148 | WNK1 | 0.32043320 |
| 149 | CAMK2D | 0.30999430 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.74193031 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.68932182 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.63694973 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.46957554 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.37581661 |
| 6 | Long-term potentiation_Homo sapiens_hsa04720 | 2.36583219 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.31085011 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.20815909 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.20099550 |
| 10 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.15107646 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.12440774 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.98078608 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 1.96687378 |
| 14 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.90731900 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.88574953 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.87786412 |
| 17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.84233878 |
| 18 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.73840517 |
| 19 | Renin secretion_Homo sapiens_hsa04924 | 1.64927006 |
| 20 | Cocaine addiction_Homo sapiens_hsa05030 | 1.59925015 |
| 21 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.56130394 |
| 22 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.51176451 |
| 23 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.49049661 |
| 24 | Sulfur relay system_Homo sapiens_hsa04122 | 1.47549689 |
| 25 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.46977905 |
| 26 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.44835037 |
| 27 | Long-term depression_Homo sapiens_hsa04730 | 1.44338674 |
| 28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.42805185 |
| 29 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.42632380 |
| 30 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.42179215 |
| 31 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.41945734 |
| 32 | Taste transduction_Homo sapiens_hsa04742 | 1.39868832 |
| 33 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.38271535 |
| 34 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.38260754 |
| 35 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.34887909 |
| 36 | Gap junction_Homo sapiens_hsa04540 | 1.32804178 |
| 37 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.30877594 |
| 38 | ABC transporters_Homo sapiens_hsa02010 | 1.26405729 |
| 39 | Glioma_Homo sapiens_hsa05214 | 1.26244983 |
| 40 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.25621074 |
| 41 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.23701392 |
| 42 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.23428261 |
| 43 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.22426968 |
| 44 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.20886547 |
| 45 | Axon guidance_Homo sapiens_hsa04360 | 1.20200840 |
| 46 | Other glycan degradation_Homo sapiens_hsa00511 | 1.19042475 |
| 47 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.12688968 |
| 48 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.11704116 |
| 49 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.08698216 |
| 50 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.07618744 |
| 51 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.07137774 |
| 52 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.05049886 |
| 53 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.02616805 |
| 54 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.02132592 |
| 55 | Melanogenesis_Homo sapiens_hsa04916 | 0.99434743 |
| 56 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.97213647 |
| 57 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.95607756 |
| 58 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.93928248 |
| 59 | Lysosome_Homo sapiens_hsa04142 | 0.92565271 |
| 60 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.91992705 |
| 61 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.91735972 |
| 62 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.90665027 |
| 63 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.90600531 |
| 64 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.90266967 |
| 65 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.90178890 |
| 66 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.88058975 |
| 67 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.87471647 |
| 68 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.85783469 |
| 69 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.84063405 |
| 70 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.83808623 |
| 71 | Endometrial cancer_Homo sapiens_hsa05213 | 0.82667950 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.81784796 |
| 73 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.80976250 |
| 74 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.80823313 |
| 75 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.80757737 |
| 76 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.80157001 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.79714913 |
| 78 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.79472743 |
| 79 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.78131464 |
| 80 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.78074440 |
| 81 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.74935553 |
| 82 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.71551774 |
| 83 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.71088877 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.69809875 |
| 85 | Bile secretion_Homo sapiens_hsa04976 | 0.68710579 |
| 86 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.68632119 |
| 87 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.68004302 |
| 88 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.66305955 |
| 89 | Mineral absorption_Homo sapiens_hsa04978 | 0.65745843 |
| 90 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.65626021 |
| 91 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.65365722 |
| 92 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.64312157 |
| 93 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.64091029 |
| 94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63842602 |
| 95 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.62479222 |
| 96 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.61736678 |
| 97 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.61444912 |
| 98 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.61297749 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60883210 |
| 100 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.60212876 |
| 101 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.59959778 |
| 102 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.59778167 |
| 103 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.59295325 |
| 104 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.59062181 |
| 105 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.58807268 |
| 106 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.57047322 |
| 107 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.55445156 |
| 108 | Endocytosis_Homo sapiens_hsa04144 | 0.55166467 |
| 109 | Peroxisome_Homo sapiens_hsa04146 | 0.54757808 |
| 110 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.54106210 |
| 111 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.51533489 |
| 112 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.49928127 |
| 113 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.48586033 |
| 114 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.48484366 |
| 115 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.47480287 |
| 116 | Phototransduction_Homo sapiens_hsa04744 | 0.47103530 |
| 117 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.46917479 |
| 118 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46740784 |
| 119 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46205241 |
| 120 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.45527309 |
| 121 | Colorectal cancer_Homo sapiens_hsa05210 | 0.44993034 |
| 122 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.44673005 |
| 123 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.44528670 |
| 124 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.44016136 |
| 125 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.43777525 |
| 126 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.43160127 |
| 127 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.42910904 |
| 128 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.42308804 |
| 129 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.42192563 |
| 130 | Prion diseases_Homo sapiens_hsa05020 | 0.41993475 |
| 131 | Platelet activation_Homo sapiens_hsa04611 | 0.41845066 |
| 132 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.41804260 |
| 133 | Circadian rhythm_Homo sapiens_hsa04710 | 0.40654641 |
| 134 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.40522646 |
| 135 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.38682964 |
| 136 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.38191080 |
| 137 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.37854770 |
| 138 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.35573502 |
| 139 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.35121709 |
| 140 | Insulin resistance_Homo sapiens_hsa04931 | 0.35042001 |
| 141 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.34540515 |
| 142 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.33623835 |

